324 related articles for article (PubMed ID: 16245241)
1. Antibody-mediated pure red-cell aplasia (PRCA): the Spanish experience.
Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; de Francisco AL; Aljama P;
J Nephrol; 2005; 18(4):382-7. PubMed ID: 16245241
[TBL] [Abstract][Full Text] [Related]
2. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin-induced, antibody-mediated pure red cell aplasia.
Rossert J;
Eur J Clin Invest; 2005 Dec; 35 Suppl 3():95-9. PubMed ID: 16281965
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
[TBL] [Abstract][Full Text] [Related]
5. A cross-sectional immunosurveillance study of anti-EPO antibody levels in CRF patients receiving epoetin alfa in 5 Ontario Renal Centers.
Wu G; Wadgymar A; Wong G; Ting R; Nathoo B; Mendelssohn D; Pandeya S; Sapir D; Tam P
Am J Kidney Dis; 2004 Aug; 44(2):264-9. PubMed ID: 15264184
[TBL] [Abstract][Full Text] [Related]
6. Antibody-mediated pure red cell aplasia related with epoetin-beta pegol (C.E.R.A.) as an erythropoietic agent: case report of a dialysis patient.
Shingu Y; Nakata T; Sawai S; Tanaka H; Asai O; Tamagaki K; Nakatani K
BMC Nephrol; 2020 Jul; 21(1):275. PubMed ID: 32664894
[TBL] [Abstract][Full Text] [Related]
7. What is antibody-mediated pure red cell aplasia (PRCA)?
Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
Carson KR; Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
[TBL] [Abstract][Full Text] [Related]
9. [Pure red cell aplasia (PRCA) induced by anti-EPO antibodies: epidemiology, diagnosis and treatment].
Janda K; Kraśniak A; Krzanowski M; Sułowicz W
Przegl Lek; 2010; 67(3):187-91. PubMed ID: 20687383
[TBL] [Abstract][Full Text] [Related]
10. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
Macdougall IC
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv9-15. PubMed ID: 15827058
[TBL] [Abstract][Full Text] [Related]
11. Pure red cell aplasia and anti-erythropoietin antibodies in patients treated with epoetin.
Casadevall N
Nephrol Dial Transplant; 2003 Nov; 18 Suppl 8():viii37-41. PubMed ID: 14608000
[TBL] [Abstract][Full Text] [Related]
12. Antibody-mediated pure red cell aplasia (PRCA): ensuring future progress by collecting data from a registry.
Aljama P; Carracedo J; Madueño JA; Ramirez R; Martin-Malo A; Martin de Francisco AL
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv27-30. PubMed ID: 15827055
[TBL] [Abstract][Full Text] [Related]
13. Incidence of erythropoietin antibody-mediated pure red cell aplasia: the Prospective Immunogenicity Surveillance Registry (PRIMS).
Macdougall IC; Casadevall N; Locatelli F; Combe C; London GM; Di Paolo S; Kribben A; Fliser D; Messner H; McNeil J; Stevens P; Santoro A; De Francisco AL; Percheson P; Potamianou A; Foucher A; Fife D; Mérit V; Vercammen E;
Nephrol Dial Transplant; 2015 Mar; 30(3):451-60. PubMed ID: 25239637
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated acquired pure red cell aplasia (PRCA) after treatment with darbepoetin.
Howman R; Kulkarni H
Nephrol Dial Transplant; 2007 May; 22(5):1462-4. PubMed ID: 17314208
[No Abstract] [Full Text] [Related]
15. Resolution of epoetin-induced pure red cell aplasia 2 years later, successful re-challenge with continuous erythropoiesis receptor stimulator.
Lim SK; Bee PC; Keng TC; Chong YB
Clin Nephrol; 2013 Sep; 80(3):227-30. PubMed ID: 23298519
[TBL] [Abstract][Full Text] [Related]
16. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
Thorpe R; Swanson SJ
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv16-22. PubMed ID: 15827053
[TBL] [Abstract][Full Text] [Related]
17. Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group.
Evens AM; Bennett CL; Luminari S
Best Pract Res Clin Haematol; 2005; 18(3):481-9. PubMed ID: 15792923
[TBL] [Abstract][Full Text] [Related]
18. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.
Cournoyer D; Toffelmire EB; Wells GA; Barber DL; Barrett BJ; Delage R; Forrest DL; Gagnon RF; Harvey EA; Laneuville P; Patterson BJ; Poon MC; Posen GA; Messner HA;
J Am Soc Nephrol; 2004 Oct; 15(10):2728-34. PubMed ID: 15466278
[TBL] [Abstract][Full Text] [Related]
19. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
[TBL] [Abstract][Full Text] [Related]
20. Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasia.
Fijal B; Ricci D; Vercammen E; Palmer PA; Fotiou F; Fife D; Lindholm A; Broderick E; Francke S; Wu X; Colaianne J; Cohen N
Pharmacogenomics; 2008 Feb; 9(2):157-67. PubMed ID: 18370845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]